Nephropathy In Type 2 Diabetes and Cardio-renal Events
Status:
Completed
Trial end date:
2019-05-01
Target enrollment:
Participant gender:
Summary
The NID-2 study, a multicentric study (21 centres enrolled), was planned in two phases:
Phase 1(observational study, completed in September 2005): after the identification of a
type-2 diabetic population with typical Diabetic Nephropathy (DN), to study of the rate of
renal and cardiovascular events during a middle term follow-up.
Phase 2(interventional study, started in October 2005): after randomization in two groups, a
group (intervention group) is treated with an intensive multifactorial intervention whose aim
is to reduce morbidity and mortality due to diabetic complications. The other group (control
group) continues the conventional therapy . To avoid bias in the treatment in each center,
the randomization was performed for centre.
Phase:
Phase 4
Details
Lead Sponsor:
Second University of Naples University of Campania "Luigi Vanvitelli"